These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29972102)

  • 1. New Therapeutic Approaches in the Management of Cardiometabolic Diseases: Bringing the Concepts Together.
    Ren J; Zhang Y
    Curr Drug Targets; 2018; 19(9):987-988. PubMed ID: 29972102
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

  • 3. Point: the metabolic syndrome still lives.
    Grundy SM
    Clin Chem; 2005 Aug; 51(8):1352-4. PubMed ID: 16040840
    [No Abstract]   [Full Text] [Related]  

  • 4. [New targets in patients with cardiometabolic risk].
    Ruilope LM; Carmena R
    Med Clin (Barc); 2007 Oct; 129(15):576-7. PubMed ID: 17988615
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular risk associated with the metabolic syndrome.
    Lindsay RS; Howard BV
    Curr Diab Rep; 2004 Feb; 4(1):63-8. PubMed ID: 14764282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome.
    Chen J; Townsend RR
    Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome.
    Dominiczak MH
    Curr Opin Lipidol; 2003 Jun; 14(3):329-32. PubMed ID: 12840663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Approaches in clinical management of metabolic syndrome. 2. Keypoints in testing for lipid metabolism anomalies and cardiovascular risk].
    Kugiyama K
    Nihon Naika Gakkai Zasshi; 2004 Apr; 93(4):683-9. PubMed ID: 15174713
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of exercise therapy to reduce cardiometabolic risk factors in overweight and obese children and adolescents: a systematic review].
    Blohm D; Ploch T; Apelt S
    Dtsch Med Wochenschr; 2012 Dec; 137(50):2631-6. PubMed ID: 23225186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myths and facts...about cardiovascular dysmetabolic syndrome.
    Munson BL
    Nursing; 2003 Jul; 33(7):74. PubMed ID: 12862024
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: addressing cardiometabolic risk.
    Haines ST
    Pharmacotherapy; 2006 May; 26(5 Pt 2):1S-2S. PubMed ID: 16715597
    [No Abstract]   [Full Text] [Related]  

  • 12. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
    Grundy SM; Brewer HB; Cleeman JI; Smith SC; Lenfant C; ;
    Circulation; 2004 Jan; 109(3):433-8. PubMed ID: 14744958
    [No Abstract]   [Full Text] [Related]  

  • 13. Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention.
    Guo S
    J Endocrinol; 2014 Feb; 220(2):E1-3. PubMed ID: 24431466
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome, inflammation and atherosclerosis.
    Paoletti R; Bolego C; Poli A; Cignarella A
    Vasc Health Risk Manag; 2006; 2(2):145-52. PubMed ID: 17319458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic syndrome and the role of the polypill in the prevention of its complications].
    Rosolová H
    Vnitr Lek; 2017; 63(10):712-716. PubMed ID: 29127755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidaemia and cardiovascular disease: cardiovascular disease and the metabolic syndrome: further research or more implementation?
    Hanna FW
    Curr Opin Lipidol; 2002 Dec; 13(6):697-9. PubMed ID: 12441895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metabolic syndrome: another chance to make an integrated health intervention].
    Aguilar Hurtado E
    Aten Primaria; 2006 Jun; 38(2):80-1. PubMed ID: 16828010
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolic syndrome in children and adolescents].
    Brandão AP; Brandão AA; Berenson GS; Fuster V
    Arq Bras Cardiol; 2005 Aug; 85(2):79-81. PubMed ID: 16113843
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes.
    Mikhailidis DP; Press M
    Expert Opin Pharmacother; 2007 Dec; 8(17):3009-20. PubMed ID: 18001259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
    Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA
    Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.